The HCPLive endocrinology page is a comprehensive resource for clinical news and insights on endocrine system conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for diabetes, hormonal disease, and more.
February 2nd 2025
Once-weekly tirzepatide may be an alternative to daily hormone shots in patients with congenital generalized lipodystrophy.
HCPLive Endocrinology's flagship diabetes podcast, hosted by Diana Isaacs, PharmD, and Natalie Bellini, DNP
Soda, Pop, Coke: Who Drinks What and Where?
September 21st 2015In an effort to fight obesity and diabetes and promote healthier diet and lifestyle choices through targeted interventions, public health officials determined which regions of the US have the highest levels of soda and other sugar-sweetened beverage consumption.
Massive Weight Loss Patients Appear Significantly Older than They Are Prior to Facial Surgery
Massive weight loss (MWL) provides obvious health benefits, including reducing morbidity and mortality risks, but it brings some medical and psychological challenges as well. MWL patients are often left with excessive amounts of sagging skin, particularly in the thighs, under the arms, around the abdomen, and around the face.
Precision Medicine Applications in Hypogonadism and Other Areas of Men's Health
September 10th 2015Precision medicine's role in the management of hypogonadism is still in its formative stages. Researchers suggest that identifying biomarkers associated with individual patients' treatment responses is possible.
My Weight Loss Avatar: A Buddy that Motivates
September 10th 2015Researchers from the University of Washington in Seattle reported that the use of avatars (digital representations of a coach, buddy, or teacher) improved user satisfaction in interactive, online weight management programs for obese teens.
Pancreatectomy Linked to Endocrine Function Impairment and Diabetes in Women
New research into distal pancreatectomies indicates that women and overweight patients have an elevated risk of suffering endocrine function impairment that leads to glucose intolerance and diabetes mellitus.
Heart Failure, Diabetes, and Medication: An Interesting Triad
September 9th 2015A study published in Metabolic Syndrome and Related Disorders indicates that sodium glucose cotransporter-2 inhibitors (SGLT2 inhibitors, which affect both supply and demand pathways in the heart) may be the preferred treatment for diabetics with heart failure.
Predicting Type 2 Diabetes: Birth Weight as a Surrogate
September 9th 2015Fetal exposure to severe starvation or stress appears to elevate risk of hyperglycemia or type 2 diabetes (T2D) later in life. Similarly, low birth weight has been associated with glucose intolerance, suppressed insulin secretory capacity, and increased risk of T2D.
Children with Lupus and Diabetes Are Likely to Also Have Depression
Children with systemic lupus erythematosus (SLE)/mixed connective tissue disease (MCTD) often suffer from significant bouts of depression and potentially suicide ideation, a study in the Journal of Pediatrics determined.
Growing Evidence that Insulin Plays a Role in Etiology and Severity of Acne Vulgaris
A study in Postᶒpy adds to the growing evidence of a link between insulin and carbohydrate metabolism in the etiology and severity of acne vulgaris. While the clinical evidence on this connection is still disputed, the majority of recent studies has pointed to a significant connection between the condition and insulin levels.
FDA Warning: Disabling Joint Pain Seen in Diabetes Drugs
The US Food and Drug administration today issued a warning that the type 2 diabetes medicines sitagliptin (Januvia/Merck) linagliptin (Tradjenta/BI), and alogliptin (Nesina/Takeda) "may cause joint pain that can be severe and disabling."
Alopecia Areata Associated with Significant Comorbidities
A systematic review of alopecia areata (AA) in Clinical, Cosmetic & Investigational Dermatology highlighted the unpredictability and lack of treatment options for the condition. But it also pointed to a larger problem: more than half of patients with AA experience poor health-related quality of life (QOL). Patients with AA are at risk for depression and anxiety, atopy, vitiligo, thyroid disease, and other autoimmune conditions.
Pituitary Incidentaloma Treatment Guideline
August 21st 2015It is unclear how many people have pituitary incidentaloma, but imaging and autopsy studies indicate they are quite common and occur in up to one-third of patients. Fortunately, the vast majority of these serendipitously discovered tumors are clinically insignificant. A management guideline in the Annals of Endocrinology brings endocrinologists up to date on current thinking about pituitary incidentaloma management.
Fighting Fat with Fitbit, Text Messages, and Other Electronic Interventions to Promote Exercise
August 21st 2015Most self-improvement intervention programs rely on self-monitoring, or increased awareness of bad habits, to help people change their behaviors. Traditionally, programs have used diaries, calendar notes, or check-ins at daily or weekly meetings to help individuals recognize and replace unhelpful routines. The October 2015 issue of Telemedicine and e-Health includes a study that describes how simple electronic feedback can help people with weight problems.
Diagnosing and Treating Exocrine Pancreatic Insufficiency in Patients with Celiac Disease
New research concludes that the association between celiac disease and exocrine pancreatic insufficiency (EPI) is strong enough that physicians should check for EPI when celiac patients suffer malnutrition or gastric distress despite adherence to prescribed diets.
Patients with the cystic fibrosis transmembrane conductance regulator gating mutation G551D have insufficient ion transport due to reduced channel-open probability. New information suggests that increased ion transport reduces disease burden in the pancreas, which prevents cystic fibrosis patients from digesting food properly and leads to exocrine pancreatic insufficiency in up to 90% of all cases.
Tumor Necrosis Factor Inhibitors and NAFLD
August 11th 2015Nonalcoholic fatty liver disease (NAFLD) is now the most common chronic liver disease reported in the United States. Some researchers have hypothesized that TNF-α, as a mediator of inflammation, might be a therapeutic target for NAFLD since inflammation seems to be a component of its etiology.